An anti-CTLA-4 heavy chain-only antibody with enhanced T-reg depletion shows excellent preclinical efficacy and safety profile (vol 119, e2200879119, 2022)
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要